This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2 - 4 November 2021
Delivered in GMT time zone

Hangzhou Tigermed Consulting Co., Ltd


Hangzhou Tigermed Consulting Co., Ltd(stock symbol: 300347) is a leading Contract Research Organization (CRO) in China dedicated to provide professional full clinical trial services. Since inception in 2004, Tigermed has been committed to accelerating medical product development with cost efficiency and quality.

Headquartered in Hangzhou, Tigermed operates 33 subsidiaries, 95 offices across China and 11 overseas offices in Hong Kong China, Taiwan China, USA, Switzerland, Korea, Australia, Japan, Malaysia, Singapore, India and Romania with over 4000 full time staffs. Tigermed has serviced more than 600 local and global clients in the conduct of over 1500 clinical trials. Tigermed is recognized as “The Innovative Clinical CRO” in China,owning to our involvement in over 160 innovative drugs.